SCR 45 Hawaii Senate · 2026 Regular Session

SUPPORTING THE DEPARTMENT OF HEALTH'S EFFORTS TO COORDINATE THE STOCKPILING OF A THREE-YEAR SUPPLY OF MIFEPRISTONE.

This Senate Concurrent Resolution urges Hawaii's Department of Health to coordinate the stockpiling of a three-year supply of mifepristone, a medication commonly used in medical abortions. The resolution is based on concerns about potential disruptions to the medication's supply chain and aims to ensure continued access to abortion care within the state. It directs the Department of Health to determine the appropriate quantities for this stockpile and requires sending a copy of the resolution to the state's health director. The measure does not mandate specific actions but serves as a formal recommendation to the health department regarding medication availability.

Issues: ✓ Healthcare

Bill status passed 3 of 5 stages cleared

Introduction

Mar 2026

Committee Review

Apr 2026

Senate Passage

Apr 2026

House Passage

Governor

Introduced Mar 10, 2026 Last action Apr 10, 2026

Maddy AI version diff · 1 comparison

What changed between versions

SCR45 → SCR45_SD1 · 4 edits

MODERATE

The bill was amended to change the Senate's stance from 'urging' the Department of Health to 'supporting' their existing efforts to stockpile mifepristone. Additionally, the text was updated to clarify that the current supply expires in 2029 and has a shelf life of up to five years, while removing references to a specific partner hospital and adjusting formatting details.

Scope change

The bill's scope shifted from a directive urging the creation of a stockpile to an expression of support for the Department of Health's ongoing stockpiling efforts.

REQUIREMENT

Changed the legislative directive from 'urging' the Department of Health to 'supporting' the Department's existing efforts to coordinate the stockpiling of mifepristone.

Added a new clause stating the Department of Health is committed to maintaining a three-year supply and that the current supply expires in 2029.

DEFINITION

Updated the description of mifepristone's shelf life from exactly five years to 'up to five years'.

TECHNICAL

Removed a specific reference to the Kapiolani Medical Center for Women and Children as a partner in maintaining the supply.

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 10, 2026

Committee

Referred to HLT, referral sheet 28

lower

Apr 9, 2026

Introduced

Received from Senate (Sen. Com. No. 451) in amended form (SD 1).

lower

Apr 9, 2026

Upper · Passed

Report and Resolution Adopted as amended (SD1). Aye(s) with reservations: none. Noes, 4 (Senator(s) Awa, DeCorte, Fevella, Gabbard). Transmitted to House.

upper

Apr 8, 2026

Upper · Passed

Reported from HHS (Stand. Com. Rep. No. 3482) with recommendation of adoption, as amended (SD 1).

upper

Mar 30, 2026

Upper · Passed

The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 3 Aye(s): Senator(s) San Buenaventura, McKelvey, Kanuha; Aye(s) with reservations: none ; 1 No(es): Senator(s) Fevella; and 1 Excused: Senator(s) Keohokalole.

upper

Mar 27, 2026

Upper · Passed

The committee(s) on HHS has scheduled a public hearing on 03-30-26 1:07PM; Conference Room 225 & Videoconference.

upper

Mar 19, 2026

Committee

Referred to HHS.

upper

Mar 10, 2026

Introduced

Offered.

upper

3 primary · 2 co-sponsors